GBAF Logo
Global Banking & Finance Awards® 2026 Nominations open, free to enter Nominate now →
A

Aarti Drugs AARTIDRUGS.NS · INR

Health Care · NSE · 🇮🇳 India

Compare

499.75

+11.86%

Close of 9 Nov 2026, in INR

Search any instrument

Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.

At a glance

Figures in INR, from our data supplier.

FY2026

Revenue

₹25.65bn

FY2017FY2026

Net income

₹1.95bn

FY2017FY2026

Free cash flow

₹490.9m

FY2017FY2026

Shareholders' equity

₹15.49bn

FY2017FY2026

Income statement

Fiscal years

FY2026FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017
Revenue₹25.65bn₹23.87bn₹25.29bn₹27.16bn₹24.89bn₹21.55bn₹18.06bn₹15.61bn₹12.44bn₹11.95bn
Research and development—₹130.4m₹120.2m₹94.4m₹78.2m₹86.0m₹87.4m₹85.6m₹40.8m₹38.0m
Operating income₹2.42bn₹7.33bn₹2.69bn₹2.65bn₹2.88bn₹3.96bn₹2.13bn₹1.66bn₹1.65bn₹1.17bn
Net income₹1.95bn₹1.68bn₹1.71bn₹1.66bn₹2.05bn₹2.80bn₹1.41bn₹897.5m₹823.1m₹805.6m
Diluted earnings per share21.3618.4218.7818.0922.1430.2815.179.638.738.44

Balance sheet

At each fiscal year end

FY2026FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017
Total assets₹28.15bn₹25.75bn₹24.32bn₹24.21bn₹22.08bn₹17.66bn₹15.77bn₹14.63bn₹13.88bn₹11.77bn
Cash and short-term investments₹242.8m₹226.1m₹89.3m₹211.7m₹216.1m₹219.8m₹67.7m₹46.4m₹32.9m₹31.5m
Total liabilities₹12.66bn₹12.05bn₹11.50bn₹12.29bn₹11.72bn₹8.53bn₹9.24bn₹9.19bn₹9.33bn₹7.67bn
Debt₹5.77bn₹6.15bn₹5.64bn₹6.09bn₹5.43bn₹3.51bn₹3.89bn₹5.07bn₹5.46bn₹4.79bn
Shareholders' equity₹15.49bn₹13.69bn₹12.82bn₹11.92bn₹10.36bn₹9.13bn₹6.52bn₹5.43bn₹4.55bn₹4.11bn
Shares outstanding91m91m91m92m93m93m93m93m94m95m

Cash flow

Fiscal years

FY2026FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017
Cash from operations₹2.22bn₹2.45bn₹3.59bn₹1.34bn₹696.4m₹1.55bn₹2.51bn₹1.43bn₹697.7m₹1.75bn
Capital spending−₹1.73bn−₹1.77bn−₹2.26bn−₹1.65bn−₹1.52bn−₹881.3m−₹479.9m−₹742.7m−₹745.3m−₹1.09bn
Free cash flow₹490.9m₹674.2m₹1.33bn−₹304.7m−₹823.4m₹667.2m₹2.03bn₹688.2m−₹47.7m₹657.6m
Dividends paid−₹181.7m−₹90.6m−₹92.7m−₹94.0m−₹95.1m−₹232.1m−₹70.3m−₹24.3m−₹24.3m−₹24.3m

Latest quarters

By quarter end

Jun 2026Mar 2026Dec 2025Sept 2025Jun 2025Mar 2025Dec 2024Sept 2024
Revenue₹7.03bn₹7.20bn₹6.02bn₹6.53bn₹5.91bn₹6.77bn₹5.57bn₹5.98bn
Operating income₹797.4m₹777.6m₹370.9m₹680.3m₹593.6m₹803.2m₹598.3m₹533.2m
Net income₹501.7m₹551.9m₹405.4m₹452.8m₹539.1m₹628.6m₹370.5m₹350.1m
Diluted earnings per share5.506.054.444.965.916.894.063.84
Cash from operations———₹1.52bn—₹2.44bn—₹1.68bn
Capital spending———−₹943.0m—−₹1.77bn—−₹897.0m
Free cash flow———₹580.0m—₹674.0m—₹784.0m
Total assets—₹28.15bn—₹26.12bn—₹25.75bn—₹24.30bn
Cash and short-term investments—₹242.8m₹245.4m₹245.4m₹226.1m₹226.1m₹295.6m₹295.6m
Debt—₹5.77bn—₹5.73bn—₹6.15bn—₹5.90bn
Shareholders' equity—₹15.49bn₹14.69bn₹14.68bn₹13.69bn₹13.69bn₹12.78bn₹12.77bn

Financial ratios

Data as of 22 Sept 2026

FY2026FY2025FY2024FY2023FY2022FY2021FY2020
Operating margin9.4%30.7%10.6%9.8%11.6%18.4%—
Net margin7.6%7.0%6.8%6.1%8.2%13.0%—
Return on equity12.6%12.3%13.4%13.9%19.8%30.7%—
Return on assets6.9%6.5%7.0%6.9%9.3%15.9%—
Free cash flow yield10.2%10.9%15.1%7.6%5.6%6.2%—
Revenue growth7.5%-5.6%-6.9%9.1%15.5%19.3%—
Earnings growth15.9%-1.9%3.1%-18.9%-26.9%98.3%—
Current ratio1.59x1.60x1.66x1.60x1.48x1.78x—
Debt to equity0.37x0.45x0.44x0.51x0.52x0.38x—
Equity ratio55.0%53.2%52.7%49.2%46.9%51.7%—
Interest coverage7.19x20.43x7.09x7.13x12.06x15.09x—
R&D as a share of sales—0.5%0.5%0.3%0.3%0.4%0.5%
Buybacks as a share of market value0.0%0.0%0.7%0.7%0.0%0.6%—

Growth per year

Compound annual rate

3 years5 years10 years
Revenue-1.9%3.5%8.5%
Operating income-2.9%-9.4%9.6%
Net income5.4%-7.0%11.0%

Average margins

Over each period

1 year3 years5 years10 years
Operating margin19.7%14.8%14.8%13.6%
Net margin7.3%6.9%8.0%7.6%

Valuation history

At each fiscal year end

FY2026FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017
Price to earnings21.422.324.527.020.818.046.515.016.519.0
Price to sales1.61.61.71.71.72.33.60.91.11.3

Dividends and splits

Per share, in the currency the company pays

Paid for 4 years. Last went ex-dividend on 9 Feb 2026.

FY2026FY2025FY2024FY2023FY2022FY2021FY2020FY2019
Paid in the year2.001.001.001.001.002.500.750.25
  • 4-for-1 split · 30 Sept 2020
  • 2-for-1 split · 24 Mar 2015

Sources and methodology

Data on this tab
Our data supplier
Chart on the Overview
TradingView

Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.